APOE and dementia: It is plausible that the efficacy of glucose-lowering therapies for dementia outcomes may differ by sex and APOE4 status due to differences in glucose metabolism.58,59 Future studies reporting dementia outcomes by APOE4 status and sex are required to evaluate this.